A Phase 2 Indication Identification Study of LY2523355 in Patients With Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck.
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Litronesib (Primary)
- Indications Colorectal cancer; Gastric cancer; Head and neck cancer; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Prostate cancer; Squamous cell cancer
- Focus Therapeutic Use
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Sep 2012 Planned end date changed from 1 Oct 2013 to 1 Jan 2013 as reported by ClinicalTrials.gov record.